IE
IE · IE · IE-PA-EU/1/12/809/019-020
Betmiga 8 mg/ml Granules for prolonged-release oral suspension
ATC G04BD12
Last synced from HPRA (Ireland) on
Identification
ManufacturerAstellas Pharma Europe B.V.
CountryIE (IE)
ATC codeG04BD12
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/12/809/019-020
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Prolonged-release granules for oral suspension",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"G04BD12"
],
"strength": null,
"pa_number": "EU/1/12/809/019-020",
"substances": [
"Mirabegron"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "22/08/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code G04BD12.
Access this data programmatically
Query Betmiga 8 mg/ml Granules for prolonged-release oral suspension and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.